A machine learning–driven web tool based on 13 standard patient metrics demonstrates strong predictive performance for MASLD, ...
A review of machine learning (ML) models developed to support the management of chronic lymphocytic leukemia (CLL) have demonstrated positive outcomes, including accurate diagnosis and improved work ...
Imagine a future where Artificial Intelligence (AI) can forecast medical conditions years before any symptoms appear. What ...
Experts weigh in on the most promising AI applications, from diabetic retinopathy screening to smarter insulin delivery, and the barriers that remain to widespread adoption and access.
The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds-those with high potency, selectivity, and favorable metabolic properties-at the earliest stages ...
An innovative biotech startup founded by researchers at Washington University School of Medicine in St. Louis has been acquired by Lunit, a leading company in developing AI-based technologies for ...